Dr. Michael Humeniuk
Claim this profileSpartanburg Medical Center
Expert in Cancer
Studies Tumors
22 reported clinical trials
40 drugs studied
Area of expertise
1Cancer
Global LeaderStage I
Stage IV
Stage II
2Tumors
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Michael Humeniuk is currently running
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Pembrolizumab + Gemcitabine
for Bladder Cancer
This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does not respond to Bacillus Calmette-Guerin (BCG) treatment. Chemotherapy drugs, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the patient's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Adding pembrolizumab to gemcitabine may delay the return of BCG-unresponsive bladder cancer for longer period compared to gemcitabine alone.
Recruiting1 award Phase 223 criteria
More about Michael Humeniuk
Clinical Trial Related7 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Michael Humeniuk has experience with
- Cisplatin
- Nivolumab
- Pembrolizumab
- Carboplatin
- Ipilimumab
- Gemcitabine Hydrochloride
Breakdown of trials Michael Humeniuk has run
Cancer
Tumors
Bladder Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Humeniuk specialize in?
Michael Humeniuk focuses on Cancer and Tumors. In particular, much of their work with Cancer has involved Stage I patients, or patients who are Stage IV.
Is Michael Humeniuk currently recruiting for clinical trials?
Yes, Michael Humeniuk is currently recruiting for 8 clinical trials in Spartanburg South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Michael Humeniuk has studied deeply?
Yes, Michael Humeniuk has studied treatments such as Cisplatin, Nivolumab, Pembrolizumab.
What is the best way to schedule an appointment with Michael Humeniuk?
Apply for one of the trials that Michael Humeniuk is conducting.
What is the office address of Michael Humeniuk?
The office of Michael Humeniuk is located at: Spartanburg Medical Center, Spartanburg, South Carolina 29303 United States. This is the address for their practice at the Spartanburg Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.